Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nordic phase II study of dose-intensive induction and high-dose consolidation with autologous stem cell rescue in peripheral T-cell lymphomas
2006-000389-35Phase 2Completed
- Sponsor
- Nordic Lymphoma Group
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cyclophosphamide in peripheral T-cell lymphoma (PTCL), sponsored by Nordic Lymphoma Group. Started May 2006; status: completed.
02
Drugs
cyclophosphamide
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on 2006-000389-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000389-35.